Clostridium Aerogenes

Clostridium perfringens is a serious trauma infectious disease*, bacteria invade muscle tissue, multiply rapidly, release aggressive enzymes, dissolve tissue causing necrosis, and form a large amount of gas, causing tissue emphysema, compressing soft tissue, obstructing blood supply , more severe muscle necrosis, local serous exudation, forming diffuse edema. The infection spreads rapidly, causing large pieces of tissue to die. Clostridium perfringens, as a conditional pathogenic bacteria, is also a common bacterium in the intestinal tract, and it also exists exclusively in external environments such as water and soil; in actual production, the rate of subclinical infection caused by it is significantly higher than that of clinical infection, mainly It is characterized by the reduction of animal production performance and feed remuneration, increased mortality of livestock and poultry, reduced feed conversion rate, slow growth, diarrhea and necrosis of intestinal mucosa, resulting in serious economic benefit reduction. With the deepening of breeding producers' awareness of the hazards of Clostridium perfringens, targeted anti-clostridium antibiotics will be selected for feeding in daily production or feed formulations to reduce Clostridium infection, promote the growth of livestock and poultry, and improve the quality of food. purpose of production efficiency. However, with the implementation of the ban on antibiotics in feed in 2020 and the withdrawal of antibiotics and antibiotics additives, alternative or anti-clostridia functional probiotic products are a good choice.